BRAF and cancer: At the same year, Choi et al. (2014) [29], found more frequent NIS methylation, in six specific CpG sites in the promoter region (− 191 to + 73), in cases of BRAF V600E carrier PTC samples than surrounding normal (SN) tissues (normal 29% vs. cancer 58%).